Professor Jonathan Shaw is Deputy Director (Clinical and Population Health) at Melbourne’s Baker Heart and Diabetes Institute, where his research focuses on epidemiology and clinical research in diabetes, and he is also a consultant physician in the diabetes services. He has authored over 600 peer-reviewed scientific papers, is the Chair of the Diabetes Advisory Group to the Australian Institute of Health and Welfare, President-Elect of the Australian Diabetes Society, and a Past-President of the International Diabetes Epidemiology Group. He has appeared on a number of the lists of the world’s most highly-cited researchers.

Professor Moon Sun-Joon is an endocrinologist and assistant professor at Kangbuk Samsung Hospital, Sungkyunkwan University, where he leads the Artificial Pancreas Clinic—one of Korea's first clinical programs dedicated to advancing diabetes technology. He serves on the CGM Research Committees of the Korean Diabetes Association (KDA), edits the CGM section of the KDA clinical guideline, and is a faculty member of ATTD-ASIA. His research focuses on CGM, automated insulin delivery systems, and smart insulin pens, with clinical trials spanning gestational diabetes, cardiac surgery, type 2 diabetes, and smart-pen decision support systems.

Dr Jennifer Snaith is clinical researcher and Endocrinologist who leads the Diabetes in Youth service at St Vincent’s Hospital, Sydney. Her research interest is the intersection between type 1 diabetes, metabolic and cardiovascular health. She was awarded the UNSW Dean’s Award for her PhD, a study of the effect of metformin on muscle and liver insulin resistance in type 1 diabetes, assessed using hyperinsulinaemic-euglycaemic clamps. She is involved in the conduct of adjunctive therapies clinical trials in type 1 diabetes through the Garvan Institute of Medical Research. Active or completed trials include the INTIMET study (metformin), RESET1 (semaglutide) and TIRTLE1 (tirzepatide). Jen’s post-doctoral work is a supported by Breakthrough T1D Australia.

Dr Audrey Kong is an Endocrinologist and PhD candidate at The University of Melbourne. Her research focuses on improving health outcomes and quality of life for people living with chronic diseases, particularly diabetes. She has a strong interest in the use of diabetes technologies to enhance care, support self-management, and improve clinical outcomes. Through her clinical and research work, she aims to advance evidence-based approaches that make diabetes care more effective, accessible, and patient-centered.

Professor Young Min Cho earned his MD and PhD from Seoul National University College of Medicine and completed his clinical training at SNU Hospital. During 2009–2010, he spent time as a Visiting Scholar at the University of British Columbia, focusing on gastrointestinal endocrinology. His work mainly involves diabetes, obesity, and gut hormones. Dr. Cho participates in clinical trials for new pharmacologic agents and digital health tools, striving to contribute to the field of metabolic diseases through both patient care and translational research.